FDA — authorised 15 September 2015
- Application: NDA207070
- Marketing authorisation holder: BOEHRINGER INGELHEIM
- Local brand name: SPIRIVA RESPIMAT
- Indication: SPRAY — INHALATION
- Status: approved
🇺🇸 fluticasone/salmeterol, tiotropium in United States
FDA authorised fluticasone/salmeterol, tiotropium on 15 September 2015
Marketing authorisation
Other Respiratory / Pulmonology approved in United States
Frequently asked questions
Is fluticasone/salmeterol, tiotropium approved in United States?
Yes. FDA authorised it on 15 September 2015.
Who is the marketing authorisation holder for fluticasone/salmeterol, tiotropium in United States?
BOEHRINGER INGELHEIM holds the US marketing authorisation.